Recent Advances in Hydrogels: Ophthalmic Applications in Cell Delivery, Vitreous Substitutes, and Ocular Adhesives
Overview
Affiliations
With the prevalence of eye diseases, such as cataracts, retinal degenerative diseases, and glaucoma, different treatments including lens replacement, vitrectomy, and stem cell transplantation have been developed; however, they are not without their respective shortcomings. For example, current methods to seal corneal incisions induced by cataract surgery, such as suturing and stromal hydration, are less than ideal due to the potential for surgically induced astigmatism or wound leakage. Vitrectomy performed on patients with diabetic retinopathy requires an artificial vitreous substitute, with current offerings having many shortcomings such as retinal toxicity. The use of stem cells has also been investigated in retinal degenerative diseases; however, an optimal delivery system is required for successful transplantation. The incorporation of hydrogels into ocular therapy has been a critical focus in overcoming the limitations of current treatments. Previous reviews have extensively documented the use of hydrogels in drug delivery; thus, the goal of this review is to discuss recent advances in hydrogel technology in surgical applications, including dendrimer and gelatin-based hydrogels for ocular adhesives and a variety of different polymers for vitreous substitutes, as well as recent advances in hydrogel-based retinal pigment epithelium (RPE) and retinal progenitor cell (RPC) delivery to the retina.
Vitrectomy for cases of diabetic retinopathy.
Shaikh N, Kumar V, Ramachandran A, Venkatesh R, Tekchandani U, Tyagi M Indian J Ophthalmol. 2024; 72(12):1704-1713.
PMID: 39186637 PMC: 11727963. DOI: 10.4103/IJO.IJO_30_24.
Biopolymeric Innovations in Ophthalmic Surgery: Enhancing Devices and Drug Delivery Systems.
Wu K, Khan S, Liao Z, Marchand M, Tran S Polymers (Basel). 2024; 16(12).
PMID: 38932068 PMC: 11207407. DOI: 10.3390/polym16121717.
Hydrogels in Ophthalmology: Novel Strategies for Overcoming Therapeutic Challenges.
Wu K, Akbar D, Giunta M, Kalevar A, Tran S Materials (Basel). 2024; 17(1).
PMID: 38203940 PMC: 10780040. DOI: 10.3390/ma17010086.
Biomaterials used for tissue engineering of barrier-forming cell monolayers in the eye.
Sasseville S, Karami S, Tchatchouang A, Charpentier P, Anney P, Gobert D Front Bioeng Biotechnol. 2023; 11:1269385.
PMID: 37840667 PMC: 10569698. DOI: 10.3389/fbioe.2023.1269385.
Soucy J, Aguzzi E, Cho J, Gilhooley M, Keuthan C, Luo Z Mol Neurodegener. 2023; 18(1):64.
PMID: 37735444 PMC: 10514988. DOI: 10.1186/s13024-023-00655-y.